US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

TERN Terns Pharmaceuticals Inc

5.50

-0.26 (-4.51%)

Fuera de horario

Última actualización: 16:51:02

Retrasado por 15 minutos

Form 3 - Initial statement of beneficial ownership of securities

Terns Pharmaceuticals (NASDAQ:TERN)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Terns Pharmaceuticals.

Terns Pharmaceuticals (NASDAQ:TERN)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Terns Pharmaceuticals.

Noticias sobre Terns Pharmaceuticals Inc TERN

Terns Pharmaceuticals Announces Leadership Changes
Miércoles 8 de Mayo 2024 (2 horas hace) • GlobeNewswire Inc.

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
Martes 7 de Mayo 2024 (1 día hace) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Viernes 3 de Mayo 2024 (5 días hace) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
Lunes 29 de Abril 2024 (1 semana hace) • GlobeNewswire Inc.

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
Miércoles 10 de Abril 2024 (4 semanas hace) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Jueves 14 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
Lunes 11 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Jueves 7 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martes 5 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
Martes 27 de Febrero 2024 (2 meses hace) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Jueves 15 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 14 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Terns Pharmaceuticals Inc Artículos de Noticias

Deutsche Telekom (QX)

JP Morgan Chase

Health Care Select Sector

BNP Paribas (QX)

Bank of America

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones